Company record
ProMab designs and manufactures recombinant proteins and custom monoclonal antibodies by combining bioinformatics, gene‑cloning, protein‑expression and purification, and immunology expertise. Its product portfolio includes cancer stem cells, antibodies that target cancer stem cells, markers for identifying cancer stem cells, specialized media for culturing cancer stem cells, as well as cell‑isolation and cell‑separation kits. In addition to these offerings, ProMab provides peptide synthesis, protein‑expression services, recombinant antibodies and proteins, and the production of tumor‑initiating cells together with antibodies directed at tumor‑initiating cells and tumor‑specific cell markers.
This directory record does not yet have a linked material-flow brief.